Abstract

The management of osteoarthritis: The state of knowledge in 2023

Osteoarthritis (OA) of the joints is the most common disease of the musculoskeletal system. OA causes pain and stiffness of the joints, distorts their contours and reduces joint mobility. OA also has a negative impact on the quality of life and results in disability. It most often affects the knees, hips, spine, joints of the fingers and toes, but it can affect any joint. For treatment of OA, it is recommended to use multimodal therapy based on a rational combination of different types of drugs with proven therapeutic effectiveness.

Piśmiennictwo

1. Wordliczek J, Woroń J, Targońska-Stępniak B i wsp. Leczenie bólu zapalnego – problem interdyscyplinarny widziany oczami reumatologa, neurologa, rehabilitanta, specjalisty medycyny bólu i farmakologa klinicznego. Ból 2018;19(4):11-26

2. Dobrogowski J, Wordliczek J, Woroń J (red.). Farmakoterapia bólu. Poznań: Termedia, 2014

3. Bajwa ZH, Wootton RJ, Warfield CA. Principles and Practice of Pain Medicine. New York: Mc Graw Hill, 2017

4. Malec-Milewska M, Woroń J (red.). Kompendium leczenia bólu. Warszawa: Medical Education, 2017

5. DiPiro JT, Talbert RL, Yee GC, et al. Pharmacotherapy. NewYork: McGrawHill, 2020

6. Woroń J. Korzystne i niekorzystne interakcje leków stosowanych w farmakoterapii bólu. Warszawa: Medical Education, 2018

7. Diky ChPL. http://chpl.com.pl/data_files/2012-11-20_DIKY_pl-spc-dic04cs-001-clean.pdf

Do góry